| Year |
Citation |
Score |
| 2019 |
Pathria P, Takahashi H, Kaneda M, Pu M, Messer K, Shepard RM, Louis TL, Shih A, Bertagnolli M, Wrasidlo W, Cheresh DA, Varner JA. Abstract 113: c-Kit-dependent tissue resident macrophage progenitors drive cancer progression Cancer Research. 78: 5006-5006. DOI: 10.1158/1538-7445.Am2018-5006 |
0.358 |
|
| 2018 |
Schmid MC, Khan SQ, Kaneda MM, Pathria P, Shepard R, Louis TL, Anand S, Woo G, Leem C, Faridi MH, Geraghty T, Rajagopalan A, Gupta S, Ahmed M, Vazquez-Padron RI, et al. Integrin CD11b activation drives anti-tumor innate immunity. Nature Communications. 9: 5379. PMID 30568188 DOI: 10.1038/S41467-018-07387-4 |
0.375 |
|
| 2017 |
Varner JA, Foubert P, Kaneda MM. PI3Kgamma activates integrin alpha4 and promotes immune suppressive myeloid cell polarization during tumor progression. Cancer Immunology Research. PMID 28963139 DOI: 10.1158/2326-6066.Cir-17-0143 |
0.354 |
|
| 2017 |
Sato-Kaneko F, Yao S, Ahmadi A, Zhang SS, Hosoya T, Kaneda MM, Varner JA, Pu M, Messer KS, Guiducci C, Coffman RL, Kitaura K, Matsutani T, Suzuki R, Carson DA, et al. Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer. Jci Insight. 2. PMID 28931759 DOI: 10.1172/Jci.Insight.93397 |
0.334 |
|
| 2017 |
Li J, Kaneda MM, Wang J, Patel K, Akers J, Ramakrishnan V, Jiang T, Carter BS, Varner JA, Chen CC. Abstract LB-207: PI3Kγ inhibition suppresses glioblastoma tumorigenicity through disruption of an IL11-STAT3-MYC signaling axis between microglia and glioblastoma Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-207 |
0.346 |
|
| 2017 |
Wettersten HI, Minami T, Kaneda MM, Seguin L, Varner JA, Weis SM, Cheresh DA. Abstract 3966: Targeting integrin αvβ3-expressing cancer stem cells to manipulate tumor-associated macrophages Cancer Research. 77: 3966-3966. DOI: 10.1158/1538-7445.Am2017-3966 |
0.352 |
|
| 2017 |
Li J, Kaneda M, Patel K, Wang J, Akers J, Ramakrishnan V, Jiang T, Carter B, Varner J, Chen C. OS06.7 PI-3Kγ inhibition suppresses glioblastoma tumorigenicity through disruption of an IL11-STAT3-MYC signaling axis between microglia and glioblastoma Neuro-Oncology. 19: iii12-iii12. DOI: 10.1093/Neuonc/Nox036.041 |
0.321 |
|
| 2016 |
Kaneda MM, Messer KS, Ralainirina N, Li H, Leem C, Gorjestani S, Woo G, Nguyen AV, Figueiredo CC, Foubert P, Schmid MC, Pink M, Winkler DG, Rausch M, Palombella VJ, et al. PI3Kγ is a molecular switch that controls immune suppression. Nature. PMID 27642729 DOI: 10.1038/Nature19834 |
0.363 |
|
| 2016 |
Kaneda MM, Cappello P, Nguyen AV, Ralainirina N, Hardamon CR, Foubert P, Schmid MC, Sun P, Mose E, Bouvet M, Lowy AM, Valasek MA, Sasik R, Novelli F, Hirsch E, et al. Macrophage PI3Kγ drives pancreatic ductal adenocarcinoma progression. Cancer Discovery. PMID 27179037 DOI: 10.1158/2159-8290.Cd-15-1346 |
0.374 |
|
| 2016 |
Kaneda MM, Varner JA. Abstract 718: Macrophage PI3Kgamma signaling promotes cancer immune suppression Cancer Research. 76: 718-718. DOI: 10.1158/1538-7445.Am2016-718 |
0.395 |
|
| 2015 |
Gunderson AJ, Kaneda MM, Tsujikawa T, Nguyen AV, Affara NI, Ruffell B, Gorjestani S, Liudahl SM, Truitt M, Olson P, Kim G, Hanahan D, Tempero MA, Sheppard B, Irving B, et al. Bruton's Tyrosine Kinase (BTK)-dependent immune cell crosstalk drives pancreas cancer. Cancer Discovery. PMID 26715645 DOI: 10.1158/2159-8290.Cd-15-0827 |
0.372 |
|
| 2015 |
Kaneda M, Hardamon C, Schmid MC, Bouvet M, Novelli F, Hirsch E, Lowy A, Varner JA. Abstract IA22: Innate immune cell PI3K gamma as a target for suppression of pancreatic ductal adenocarcinoma Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-Ia22 |
0.392 |
|
| 2014 |
Kaneda M, Gorjestani S, Varner JA. Abstract 3650: PI3-kinase gamma controls the macrophage M1-M2 switch, thereby promoting tumor immunosuppression and progression Cancer Research. 74: 3650-3650. DOI: 10.1158/1538-7445.Am2014-3650 |
0.368 |
|
| 2013 |
Li-Byarlay H, Li Y, Stroud H, Feng S, Newman TC, Kaneda M, Hou KK, Worley KC, Elsik CG, Wickline SA, Jacobsen SE, Ma J, Robinson GE. RNA interference knockdown of DNA methyl-transferase 3 affects gene alternative splicing in the honey bee. Proceedings of the National Academy of Sciences of the United States of America. 110: 12750-5. PMID 23852726 DOI: 10.1073/Pnas.1310735110 |
0.402 |
|
| 2010 |
Kaneda MM, Sasaki Y, Lanza GM, Milbrandt J, Wickline SA. Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. Biomaterials. 31: 3079-86. PMID 20092889 DOI: 10.1016/J.Biomaterials.2010.01.006 |
0.544 |
|
| 2010 |
Myerson JW, Kaneda MM, Lanza GM, Wickline SA. 19F MRS assessment of siRNA delivery to vascular cells via perfluorocarbon nanoparticles Journal of Cardiovascular Magnetic Resonance. 12. DOI: 10.1186/1532-429X-12-S1-P103 |
0.578 |
|
| 2009 |
Southworth R, Kaneda M, Chen J, Zhang L, Zhang H, Yang X, Razavi R, Lanza G, Wickline SA. Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. Nanomedicine : Nanotechnology, Biology, and Medicine. 5: 359-67. PMID 19523428 DOI: 10.1016/J.Nano.2008.12.002 |
0.571 |
|
| 2009 |
Kaneda MM, Caruthers S, Lanza GM, Wickline SA. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Annals of Biomedical Engineering. 37: 1922-33. PMID 19184435 DOI: 10.1007/S10439-009-9643-Z |
0.512 |
|
| 2006 |
Wacker BK, Scott EA, Kaneda MM, Alford SK, Elbert DL. Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels. Biomacromolecules. 7: 1335-43. PMID 16602758 DOI: 10.1021/Bm050948R |
0.31 |
|
| 2005 |
Hughes SK, Wacker BK, Kaneda MM, Elbert DL. Fluid shear stress modulates cell migration induced by sphingosine 1-phosphate and vascular endothelial growth factor. Annals of Biomedical Engineering. 33: 1003-14. PMID 16133909 DOI: 10.1007/S10439-005-5756-1 |
0.347 |
|
| Show low-probability matches. |